Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea

Hae Il Cheong, Sang Kyung Jo, Sung Soo Yoon, Heeyeon Cho, Jin Seok Kim, Young Ok Kim, Ja Ryong Koo, Yong Park, Young Seo Park, Jae Il Shin, Kee Hwan Yoo, Doyeun Oh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare syndrome characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The major pathogenesis of aHUS involves dysregulation of the complement system. Eculizumab, which blocks complement C5 activation, has recently been proven as an effective agent. Delayed diagnosis and treatment of aHUS can cause death or end-stage renal disease. Therefore, a diagnosis that differentiates aHUS from other forms of thrombotic microangiopathy is very important for appropriate management. These guidelines aim to offer recommendations for the diagnosis and treatment of patients with aHUS in Korea. The guidelines have largely been adopted from the current guidelines due to the lack of evidence concerning the Korean population.

Original languageEnglish
Pages (from-to)1516-1528
Number of pages13
JournalJournal of Korean Medical Science
Volume31
Issue number10
DOIs
Publication statusPublished - 2016 Jan 1

Keywords

  • Atypical hemolytic uremic syndrome
  • Diagnosis
  • Guidelines
  • Treatment

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea'. Together they form a unique fingerprint.

  • Cite this

    Cheong, H. I., Jo, S. K., Yoon, S. S., Cho, H., Kim, J. S., Kim, Y. O., Koo, J. R., Park, Y., Park, Y. S., Shin, J. I., Yoo, K. H., & Oh, D. (2016). Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea. Journal of Korean Medical Science, 31(10), 1516-1528. https://doi.org/10.3346/jkms.2016.31.10.1516